Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases

Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases

<p>Abstract</p> <p>Background</p> <p>To assess the value of diffusion weighted imaging (DWI) as an early surrogate parameter for treatment response of colorectal liver metastases to image-guided single-fraction <sup>192</sup>Ir-high-dose-rate brachytherapy (...

Full description

Bibliographic Details
Main Authors:	Röhl Friedrich-Wilhelm, Pech Maciej, Fischbach Frank, Löwenthal David, Zeile Martin, Wybranski Christian, Gademann Günther, Ricke Jens, Dudeck Oliver
Format:	Article
Language:	English
Published:	BMC 2011-04-01
Series:	Radiation Oncology
Online Access:	http://www.ro-journal.com/content/6/1/43

Similar Items

Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases
by: Seidensticker Max, et al.
Published: (2010-03-01)

Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience
by: Ralph Drewes, et al.
Published: (2019-08-01)

Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space
by: Constanze Heinze, et al.
Published: (2019-09-01)

Interstitial High-Dose-Rate Brachytherapy of Liver Metastases in Oligometastatic Patients
by: Franziska Walter, et al.
Published: (2021-12-01)

Three-dimensional template combined with MR-guided iodine-125 brachytherapy for recurrent brain metastases
by: Xiangmeng He, et al.
Published: (2023-06-01)

In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction <sup>192</sup>Ir high-dose-rate brachytherapy
by: Kropf Siegfried, et al.
Published: (2011-09-01)

Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
by: Maximilian Thormann, et al.
Published: (2022-08-01)

Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases
by: Karim Salma, et al.
Published: (2024-02-01)

Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
by: Ricarda Seidensticker, et al.
Published: (2018-09-01)

Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
by: Pech Maciej, et al.
Published: (2011-04-01)

Ct- and Mr-guided interventions in radiology /
by: Mahnken, Andreas H., et al.
Published: (2009)

Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements
by: Robert Damm, et al.
Published: (2018-12-01)

Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.
by: Max Seidensticker, et al.
Published: (2014-01-01)

Respiratory motion artefacts in Gd-EOB-DTPA (Primovist/Eovist) and Gd-DOTA (Dotarem)-enhanced dynamic phase liver MRI after intensified and standard pre-scan patient preparation: A bi-institutional analysis.
by: Christian Wybranski, et al.
Published: (2020-01-01)

The role of brachytherapy in the management of brain metastases: a systematic review
Published: (2020-02-01)

Improved seed-based MR and CT image registration for prostate brachytherapy
by: Kim, Elizabeth S. (Elizabeth Seon-wha), 1979-
Published: (2005)

Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases
by: Wust Peter, et al.
Published: (2010-05-01)

Cardiac magnetic resonance imaging using an open 1.0T MR platform: a comparative study with 1.5T
by: Kosiek Ortrud, et al.
Published: (2013-01-01)

Nomenclature for using MR as a new lesion surrogate outcome
by: Coutts, S, et al.
Published: (2004)

Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2023-01-01)

First-pass myocardial stress perfusion MRI using k-t BLAST at an open MR-system: initial results in comparison to FFR measurements
by: Kosiek Ortrud, et al.
Published: (2013-01-01)

Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model
by: Max Seidensticker, et al.
Published: (2016-07-01)

MR neurography in ulnar neuropathy as surrogate parameter for the presence of disseminated neuropathy.
by: Philipp Bäumer, et al.
Published: (2012-01-01)

Monte Carlo Dosimetric Study of Percutaneous Vertebroplasty and Brachytherapy for the Treatment of Spinal Metastases
by: Payman Rafiepour, et al.
Published: (2023-10-01)

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: A phase II-study and historical comparison with the surgical approach
by: Riess Hanno, et al.
Published: (2007-04-01)

Therapeutic Outcome of MR-Guided High-Intensity Focused Ultrasound (MR-HIFU) in Solitary versus Multiple Uterine Fibroids
by: Bernd Erber, et al.
Published: (2022-08-01)

Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy
by: Jazan Omari, et al.
Published: (2019-09-01)

Iodine-125 brachytherapy for brain tumours - a review
by: Schwarz Silke B, et al.
Published: (2012-03-01)

Will MR image-guided brachytherapy be a standard of care for cervical cancer in future? An Indian perspective
by: D D Deshpande
Published: (2012-01-01)

Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
by: Menachem Z. Yondorf, et al.
Published: (2020-08-01)

CT-guided 125I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region
by: Huzheng Yan, et al.
Published: (2017-02-01)

Interstitial brachytherapy for liver metastases and assessment of response by positron emission tomography: a case report
by: Goura Kishor Rath, et al.
Published: (2010-10-01)

Needle track seeding in colorectal carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 1,107 catheter placements
by: Christine March, et al.
Published: (2022-04-01)

Chemotherapy-Induced Liver Injury in Patients with Colorectal Liver Metastases: Findings from MR Imaging
by: Francescamaria Donati, et al.
Published: (2022-03-01)

Efficacy and safety of guidewireless catheterization with a steerable microcatheter in patients scheduled for yttrium-90 radioembolization: a prospective multicenter trial
by: Zbigniew Serafin, et al.
Published: (2020-01-01)

High-dose-rate surface brachytherapy as a treatment option for renal cell carcinoma cutaneous metastases
by: Łukasz Raszewski, et al.
Published: (2021-05-01)

Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.
by: Ga Eun Park, et al.
Published: (2018-01-01)

Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging
by: Mario Federico, et al.
Published: (2019-10-01)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
by: Morgan Michalet, et al.
Published: (2022-12-01)

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
by: Shouliang Ding, et al.
Published: (2023-05-01)